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ABSTRACT 7 
Objectives. Compression garments (CG) are used by athletes in attempts to enhance performance 8 
and recovery, although evidence to support their use is equivocal. Reducing the exertion 9 
experienced during exercise may encourage sedentary individuals to increase physical activity. The 10 
aim of this study was to assess the effect of CG on walking performance (self-paced and enforced 11 
pace) and rate of perceived exertion (RPE) in adults who presented with two or more CVD risk 12 
factors. Participants (n=15, 10 female, 58.9 ± 11.5 years, BMI 27.5± 4.5 kg.m2) were recruited. 13 
Design. A repeated measures design. Methods. Participants were randomised to Modified Bruce 14 
Protocol (MPB, enforced pace), or the 6 minute walk test (6 MWT, self-paced), and completed the 15 
test wearing compression garments (CG) or normal exercise clothes (CON). Outcome measures 16 
included stage completed, gross efficiency (%) and RPE in MBP, and distance walked (m) and RPE in 6 17 
MWT. Results. In the MBP participants had a higher RPE (15.5 ±2.5 vs 14.3 ±2.2) and a lower 18 
efficiency (19.1 ±5.9 vs 21.1 ±6.7) in the CG condition compared with CON, p <0.05. In the 6 MWT 19 
participants walked 9% less in the CG condition (p<0.05) but did not have a lower RPE. Conclusion. 20 
Compared with previous studies reporting enhanced or no effects of CG on performance or RPE, this 21 
study shows adverse effects of CG in untrained individuals with CVD risk factors. The mechanisms 22 
underlying this negative effect require further exploration. Use of garments designed for the athletic 23 
individuals may not be suitable for the wider population. 24 
Keywords:  Adult, physical activity, exercise, risk, effort 25 
 26 
  27 
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INTRODUCTION 28 
The use of compression garments (CG) to facilitate sports performance and recovery is becoming 29 
increasingly popular. Originally designed for post-surgical use, with compression graduated from 30 
ankle to hip, they were used to enhance blood flow. They are also used to prevent venous pooling 31 
that frequently occurs during pregnancy and long distance travel. The commercial claims for CG 32 
suggest they can improve sports performance, and reduce fatigue and muscle injury.  Investigations 33 
into CG effects on speed1, endurance2, running economy3, oxygen consumption4 and recovery5 34 
provide mixed results. The strongest support from these studies is for a type of ‘placebo effect’ 35 
mediated by heightened feelings of support6. Wearers report lower ratings of perceived exertion 36 
(RPE)  although this is not usually accompanied by improvements in performance7. In older athletes 37 
(age 63 years) CG worn during recovery increased power output during a subsequent cycling bout8. 38 
Further, the subjects reported reduced leg discomfort during cycling, although this pain rating was 39 
not associated improved performance.  40 
As age increases, physical activity declines. Even adults that have been prescribed exercise for health 41 
reasons, frequently fail to achieve a target amount of activity. For instance, only 36% of subjects who 42 
were referred to cardiac rehabilitation fully completed their prescribed exercise sessions9. Many 43 
barriers to adherence to exercise programmes, such as access to facilities, are difficult to address. 44 
However, if the activity was made to feel more comfortable and less demanding adherence may 45 
increase. 46 
Studies to date assessing the effect of CG on performance may be limited in that participants have 47 
already have a high work capacity, so any changes seen would be minimal. Older and less physically 48 
fit individuals may have more potential for increasing performance. Theoretically, compression will 49 
increase pressure in lower limb vessels, so enhancing diffusion capacity, and enhancing exercise 50 
capacity. 51 
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Thus, the aim of this study was to determine the effects of wearing CG on RPE and walking 52 
performance in adults with CVD risk factors during prescribed workload and self-paced walking; 53 
Modified Bruce Protocol [MBP] and self-paced 6 minute walk test [6 MWT]. Externally guided 54 
exercise facilitates comparison of RPE at the same workload. In self-paced exercise, workload varies 55 
according to RPE. This dual-protocol approach was chosen in an attempt to allow better 56 
understanding of the mechanisms by which CG may influence responses to exercise and exercise 57 
performance.  58 
 59 
The primary hypothesis was that wearing CG would reduce RPE during a treadmill-based walking 60 
protocol. The second hypothesis was that wearing CG would increase walking performance in terms 61 
of stage reached (MBP) or distance walked (6 MWT). 62 
METHODS 63 
Five males and 10 females, ages 58.9 years (±11.5, range 40 to 73 years), with a BMI 27.5 (±4.5 range 64 
20.4 to 36.1 kg m2) were recruited. Ethical approval for the study was given by the University of 65 
Essex Ethics Committee. Inclusion criteria were current diagnosis of cardiovascular disease, previous 66 
myocardial infarction, type 2 diabetes or clustered metabolic risk10. Unstable angina was an 67 
exclusion criterion. Details of participant risk factors are available as supplementary material.  68 
We used a repeated measures, double randomised cross-over design that required participants to 69 
attend two separate testing sessions, one week apart, at the same time of day. Participants were 70 
asked to maintain normal activity between trials, and refrain from strenuous activity 24 hours prior 71 
to testing. Room temperature was the same in each trial (19 ○C). Participants were randomly 72 
selected to either MBP or 6 MWT group, then randomly assigned to wear CG during their first trial 73 
(Time 1) or their second trial (Time 2, see Figure 1). When not wearing CG, participants wore their 74 
own loose exercise trousers. Both walking protocols took place on a motorised treadmill (Saturn, HP-75 
Cosmos, Germany).  76 
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 77 
After 3 minutes of quiet sitting, duplicate resting blood pressure was measured (MX3Plus Omron 78 
digital blood pressure monitor HEM-742-E), with the lowest value recorded. Expired gases (Oxycon- 79 
MasterScreen™ CPX) and heart rate (Polar RCX5 G5 Oy, Finland) were continually recorded 80 
throughout the test. At the end of each stage (MPB) or each minute (6 MWT), participants were 81 
asked to report their RPE11. RPE was assessed on a 6-20 point scale (shown on a large chart) with 82 
participants verbally stating the number which best reflected their effort. Upon cessation of the test, 83 
blood pressure was recorded. Expired gas data were exported in 5 second epochs for analysis. In the 84 
CG condition, BP was measured whilst participants were wearing the CG both pre and post exercise. 85 
Height (m), weight (kg) and waist circumference (cm) were measured in duplicate using standard 86 
procedure. 87 
 88 
The Bruce Protocol has seven stages, each lasting three minutes, with speed and incline increasing at 89 
each stage. The first stage starts 2.7 km h-1 at a 10% incline and reaches 8.8 km h-1 (at 20% incline 90 
The Modified Bruce protocol has two additional; stage 1 is at 2.7 km h-1 at 0% incline, stage 2 is at 91 
2.7 km h-1 at 5% incline, and then stage 3 is the start (Stage 1) of the Bruce protocol, and continues 92 
to increase in the same manner. The test was terminated when subjects could no longer maintain 93 
the required pace (volitional exhaustion) or when heart rate exceeded age –related predicted 94 
maximum (220-age). 95 
 96 
The 6 MWT test is used to assess functional capacity in a wide range of populations with varying 97 
levels of exercise capacity. Participants usually perform the 6 MWT by walking shuttles across the 98 
ground but in the current study the test was conducted on a treadmill in order to make it more 99 
comparable to the MBP. The treadmill was set at a 1% incline to reflect natural walking. Participants 100 
were instructed to “Adjust the speed accordingly and try to go as far as you can in 6 minutes”. 101 
Page 6 of 19
Ac
ce
pte
d M
an
us
cri
pt
6 
 
Participants were allowed to increase and decrease the speed at will, but were encouraged to 102 
maintain a fast pace. Participants were blinded to speed but not to time.   103 
 104 
The CG used in the current study were Skins TM  Compression A400 Long (ankle to waist) Tights 105 
(Riverwood, Australia) and were fit for each subject according to the manufacturer’s instructions. 106 
Fabric is 76% nylon and 24% elastane. The purpose of the CG fit is to ensure that garment movement 107 
is minimal and congruent with the skin. Participants put on the CG 5 minutes before the exercise 108 
commenced. The exerted pressure was evaluated by the Picopress® pressure monitor. Coefficient of 109 
variation for this has been reported as 2.8% 12. Pressure measures were recorded at 5 anatomical 110 
locations; medial calf and posterior calf (at widest part), anterior thigh and posterior thigh (midpoint 111 
between greater trochanter and lateral epicondyle), and gluteus maximus (widest part). A pressure 112 
bladder was placed between the subject’s skin and the CG to access the pressure on each landmark.  113 
 114 
Data from MPB and 6 MWT were analysed separately. For the MBP, final completed stage, RPE, VO2 115 
(ml kg-1 min-1) and GE (gross efficiency as %) were compared using paired t-tests at the final stage 116 
that was completed across conditions. For example if stage 4 was completed in trial 1, but only stage 117 
3 competed in trial 2, then stage 3 was compared across trials. GE was calculated as mechanical 118 
power / metabolic power; GE=PO/Pmet *100, where PO is the work output (Watts) and Pmet is VO2 * 119 
[(4940*RER +16090)/60]13. RPE at exhaustion (not matched stage) is also given. 120 
 121 
For 6 MWT, distance walked (m), speed at 3 and 6 minutes (km h-1), RPE at 3 minutes and final RPE, 122 
and peak VO2 (ml kg
-1 min-1) were compared between conditions using paired t-tests. 123 
Percent change from baseline was calculated for systolic and diastolic blood pressure (mmHg) and 124 
compared using paired t-tests, for both MBP and 6 MWT. 125 
Statistical significance was set at alpha =0.05. Cohen’s d (difference in group mean / average SD) was 126 
calculated, with effect size of 0.2 considered ‘small’, 0.5 as ‘medium’ and 0.8 as ‘large’.   127 
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 128 
RESULTS 129 
Compression values (mmHg) at the five measurement points were as follows; medial calf 12.5 (±3.6), 130 
posterior calf 11.4 (±2.8), anterior thigh 5.3 (±1.7), posterior thigh 5.1 (±1.8) gluteus 5.7 (±2.0). 131 
 132 
Modified Bruce Protocol: Four of the eight participants achieved a VO2 peak more than 1SD below 133 
their age and gender predicted value14 in the CON condition. One participant continued longer in the 134 
CG condition, three continued longer in the CON condition, and four continued for a similar time (i.e. 135 
reached exhaustion during the same level) in each trial.  136 
 137 
Participants rated the CON condition as requiring less exertion (RPE at final completed stage, t (7) 138 
=3.0, p=0.02) and had a lower VO2 in the final completed stage (t (7) =3.4, p=0.01). GE was lower in 139 
the CON condition in the final stage completed across both trials (t (7) =2.8, p=0.03), see table 1. RPE 140 
at exhaustion was higher in CG condition but there was no difference between trials (p>0.05)  141 
 142 
At baseline mean blood pressure (mmHg) prior to the CON trial was 137/81 (±22/14), and in the CG 143 
trial was 138/79 (±21/11).  After exercise this increased to 168/85 (±28/13) in CON and 160/82 144 
(±20/10) in the CG condition. There was no significant difference in percent change in SBP or DBP 145 
across trials (table 1).  146 
 147 
6MWT: All participants walked within age expected norms, except one male who walked >1 SD 148 
above predicted15  All participants walked further in the CON condition. In the CON condition, 149 
participants walked an average of 9% further compared with the CG condition (t (6)=3.3, p=0.02), 150 
table 2.  151 
 152 
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Mean blood pressure (mmHg) prior to the CON trial was 139/78mmHg (±21/10), increasing to 159 153 
/72 (±29/9) and in the CG trial was 141/77 mmHg (±17/10) increasing to 172/74 (±28/9). There was 154 
no significant difference in change in SBP or DBP across trials. 155 
 156 
DISCUSSION 157 
The aims of this study were to examine the effects of CG on performance and RPE during externally 158 
and self-paced walking in adults at risk of CVD.  159 
 160 
Participants’ RPE was 1.2 points higher when wearing CG compared with CON in the MBP (with a 161 
moderate effect size of d=0.51) at a comparable time point. RPE was slightly higher (non-significant, 162 
effect size d=0.20) in the CG toward the end of 6 MWT, despite a lower self-selected walking pace.  163 
 164 
Part of the perceived exertion may have been due to the unfamiliarity with tight compression 165 
clothing. Even trained athletes, who are likely used to wearing Lycra based clothing rate CG that 166 
have a high compression value as uncomfortable. Ali et al4 found that compression above 23 mmHg 167 
was rated as uncomfortable. The compression values in the current study are much lower (rated as a 168 
medium or low compression in Ali et al’s study), but still higher than the CON (no compression) 169 
condition. Although participants used ‘positive’ words or phrases to describe the comfort of the 170 
garments, such as ‘supportive’ and ‘made me feel lighter’, the unfamiliar sensation may have altered 171 
perception. Similarly, it is possible that the increased skin temperature reported in several studies 172 
5,16,17 but not measured here, may influence the participants’ perceived exertion.  173 
 174 
Few studies to date report a positive influence of CG on whole body RPE. For example, Born et al18 175 
and Miyamoto & Kawakami19 report reduced leg muscle ‘RPE’ as a result of CG, but did not find a 176 
reduced whole body perceived exertion. However, Faulkner et al20 found both knee length and full 177 
length CG resulted in a lower RPE when completing a 400m run, compared with no compression. 178 
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Compression values (mmHg) for the full length garments reported by Faulkner20 were similar to 179 
those reported in the current study. However, participants in Faulkner’s study were young male 180 
athletes and so not comparable in terms of training status or importantly body composition. BMI of 181 
subjects in the current study ranged from 20.4 to 36.1 kg.m2. Fitting of compression garments is 182 
based on weight and height, but people in the same dimensional range are likely to vary extensively 183 
in morphology21. Given the low training status of the subjects in the current study, along with the 184 
high BMI of some, it is likely that many subjects had a high fat mass. The effects of compression on 185 
fat mass as opposed to muscle mass, and the consequent physiological effects are likely to be very 186 
different.  187 
 188 
Across both walking protocols, performance was reduced in the CG condition. In MBP participants 189 
completed fewer stages whilst wearing the CG (although there was no significant difference 190 
between trials in this protocol).  191 
 192 
Distance walked was 9% less in the CG trial in the 6 MWT (p<0.05). This is of particular importance as 193 
it more reflective of the self-paced nature of physical activity that is common in rehabilitation 194 
classes. Although some studies report increases in explosive power measures (such as counter 195 
movement jumps)16,22 few studies have found positive effects of CG on endurance performance. 196 
Kemmler et al1 showed increases in total work and work duration as part of a running to exhaustion 197 
trial as a result of lower leg CG. Similarly, Bringard et al3 reported a reduced oxygen cost of running 198 
(only at 12 km h-1). This reduced oxygen cost implies a greater efficiency. However, a far greater 199 
number of studies that used a similar protocol to the current study report no effect of CG on 200 
performance or economy. 4,6,23  In the MBP we found a higher VO2 at the same comparable stage in 201 
the CG condition. The mechanisms by which CG may increase oxygen requirement in the current 202 
study are unclear. Again, alterations in temperature will alter local, and potentially central, 203 
haemodynamics, potentially altering whole body oxygen demand. Similarly, the compression may 204 
Page 10 of 19
Ac
ce
pte
d M
an
us
cri
pt
10 
 
have altered flow rate and perfusion. Bochmannet al24 reported increases in forearm blood flow and 205 
perfusion as a result of external compression, which was enhanced by light exercise. If a similar 206 
increase in perfusion was occurring in participants in the CG condition in the current study, this may 207 
explain the increased VO2.  However, if an increase in perfusion did occur, it was not accompanied by 208 
an increase in performance or a decrease in perceived exertion, so the increase in VO2 in CG was 209 
likely due to other reasons. 210 
 211 
Lack of familiarisation to compressive clothing may have altered the normal gait of the participants. 212 
Compression alters many factors that contribute to normal gait; proprioception and balance25 and 213 
range of motion16. The reduction in range of motion was shown at the hip joint during a 60m run in 214 
healthy males wearing knee length compression shorts by Doan and colleagues. Although the 215 
demographic of the participants and the nature of the test differ in Doan’s study to the current 216 
study, it is possible that the increased resistance altered gait during the CG condition. This may have 217 
negatively influenced normal walking economy, i.e. increasing VO2. It is a limitation of this study that 218 
gait was not analysed during the exercise.  219 
 220 
Systolic blood pressure increased in all conditions as a result of exercise, as would be expected.  221 
The effect of compression of venous pooling is unclear, especially in upright postures or during 222 
exercise. At compressions of 20 to 30 mmHg (higher than reported in the current study) there is little 223 
evidence of decreased venous diameter or altered flow in healthy subjects in upright positions26. 224 
Privett and colleagues27 showed that compression stockings can help maintain blood pressure in 225 
orthostatically intolerant athletes post-exercise, but few studies report the effect of compression 226 
garments on blood pressure either during or post-exercise. MacRae and colleagues28  report small 227 
limited effects of CG on CV variables (increased cardiac output and HR drift but no effect on arterial 228 
pressure) during submaximal exercise. They conclude the mild compression commercial garments 229 
provide fails to add to the effectiveness of skeletal muscle pumps and venous valves in healthy 230 
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individuals. The current study involved adults with potentially compromised CV systems who may 231 
have limited exercise tolerance, and possibly a different response to CG. This was apparent in the 232 
MBP where four participants achieved a VO2 max lower than age expected norms. The limited 233 
exercise tolerance displayed makes comparison with athlete based studies difficult. However use of 234 
a repeated measures design reduces variability between conditions. Further the participants are 235 
highly representative of the type of individuals who receive GP exercise referral.  236 
 237 
Increases in blood pressure above normal exercise related changes could be potentially harmful for 238 
subjects who are already hypertensive. Conclusions regarding the effect of compression on blood 239 
pressure cannot be gained from this study due to the range of cardiovascular risk factors presented, 240 
the degree of hypertension and the fact that 2 participants were taking medication that mediated 241 
blood pressure. 242 
 243 
Conclusion 244 
If participants perceive exercise to be easier and more comfortable whilst wearing CG they may be 245 
encouraged to do more activity. However, walking performance and perceived effort were 246 
negatively affected by the use of compression garments in this population. It is possible that further 247 
familiarisation with the garments may reduce the participants RPE, which likely affected their 248 
performance, particularly in the 6 MWT. The effect of compression on gait and on CV strain in ‘non-249 
healthy’ populations, and also requires further assessment.  250 
 251 
Practical implications 252 
 Commercially available garments, such as the ones used in this study, are not designed for 253 
use outside the athletic population and so caution is advised in relation to their widespread 254 
use. 255 
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 Familiarisation with the garments is recommended as the constriction experienced will likely 256 
alter RPE and potentially gait. 257 
 The effects of compression garments on blood pressure in hypertensive subjects should be 258 
monitored. 259 
 260 
 261 
 262 
 263 
 264 
 265 
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Table 1. Performance, physiological and perception of effort data for Modified Bruce Protocol across 336 
two conditions (CG and CON), n=8. Data are mean ±SD.   337 
 CG CON Effect size (Cohen) 
Final completed stage 4.75 ±1.6 5.00 ±1.3  
RPE at final completed 
stage ϯ 
15.5 ±2.5* 14.3 ±2.2* d=0.51 
RPE at exhaustion 
(regardless of stage) 
15.6 ±2.4 14.8 ±2.0 d=0.36 
  2 at final stage (ml kg
-1 
min-1) ϯ 
27.3 ±5.6* 24.8 ±5.6* d=0.45 
GE (%) at final stage ϯ 19.1 ±5.9* 21.1 ±6.7* d=0.31 
HR peak (bpm) 139 ±26.2 141 ±22.7 d=0.20 
% change in SBP 20.9 ±11.2 24.1 ±10.8 d=0.29 
% change in DBP 7.9 ±20.0 4.1 ±20.0 d=0.19 
Ϯ individual stage completed across both trials, * significant difference between groups, p<0.05.  338 
 339 
  340 
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Table 2. Performance, physiological and perception of effort data for 6 minute Walk Test across two 341 
conditions (CG and CON), n=7. Data are mean ±SD.   342 
 CG CON Effect size (Cohen) 
Distance walked (m) 562  ±126* 612  ±115* d=0.44   
Final RPE 16.0 ±1.8 15.6  ±2.4 d=0.20  
Speed at 3 min (km h -1) 5.85 ±0.85 6.03 ±0.74  d=0.22  
                            (m s-1) 1.6 ±0.2 1.7 ±0.2  
Speed at 6 min (km h-1) 6.7 ±0.9 7.2 ±0.6 d=0.65  
                             (m s-1) 1.9 ±0.2 2.0 ± 0.2  
Peak VO2 (ml kg min
-1) 23.4 ± 4.3 22.7 ± 4.6 d=0.16 
% change in SBP 26.6  ±22.0 14.6  ±9.8 d=0.70 
% change in DBP 1.2  ±11.0 -6.5  ±10.1 d=0.50 
* significant difference between groups, p<0.05 343 
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Figure 1. Double randomised cross over design. 345 
6MWT (6 minute walk test), MPB (Modified Bruce Protocol), CG (Compression Garment), CON 346 
(Control condition), T1 (time1), T2 (time2) 347 
 348 
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Figure 1. Double randomised cross over design. 
Figure(s)
